Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium


On Feb. 26, 2022, Rancho Biosciences, a leading data sciences services company, launched its Single Cell Data Science (SCDS) pre-competitive consortium, with four Charter Members: Bristol Myers Squibb, Janssen Research & Development, LLC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson, Novartis and Vesalius Therapeutics. Today, Rancho Biosciences is pleased to announce the addition of BenevolentAI as the fifth Member of the SCDS consortium.

The mission of the consortium is to find a common industry standard around how single-cell datasets are created and formatted by a systematic effort to develop data models and ensure that public data are curated in a consistent way. Due to the undeniable impact of single cell transcriptomics technology on drug discovery, there continues to be an exponential growth in the use of single cell sequencing methods by pharmaceutical companies. The availability of ever-increasing amounts of single cell datasets in the public domain allows pharmaceutical companies to dramatically expand their universe of single cell experiments over those generated internally. Leveraging this vast public data lake by finding, downloading, and curating single cell data is highly laborious and time-consuming compared to the resources for collectively analyzing data by scientists to gain value for biomedical research. 

Using its deep curation expertise and know-how, Rancho has delivered 83 analysis ready datasets to date. Each dataset includes 79 curated columns of metadata, validated against a 4-entity data model built by Rancho for SCDS. Prioritized by Members, Rancho will continue to deliver an ongoing stream of harmonized single cell datasets to the consortium. Under this shared cost model, these can be delivered at much higher throughput than one single company could achieve and much more cost-effectively. New Members are welcome.

About Rancho

Founded in 2012, Rancho Biosciences is a privately held company offering services for data curation, management and analysis for companies engaged in pharmaceutical research and development. Its clients include top 20 pharma and biotech companies, research foundations, government labs and academic groups.

For more information about Rancho and SCDS consortium, contact:

Andy Hope, PhD           

[email protected]

Contact Information:
Andy Hope
Business Development
[email protected]

Original Source: Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium

Related articles

Trolls 3: Universal & DreamWorks sequel gets an official title and groovy trailer

Universal and DreamWorks have revealed the official Trolls Band Together trailer alongside the entire cast list for the...

Travel Like the Hoff: Europe’s Trainline App and Actor David Hasselhoff Team Up for Once in a Lifetime Chief Conductor Contest

One lucky winner will win the golden train ticket, receiving an epic European rail vacation created by 'The...

Swing Racquet + Paddle Announces Partnership with Industry Leader Good to Great Tennis Academy

Swing and Good to Great Embark on a Collaborative Partnership to Bring a World-Class Teaching Academy to the...

Elemental: What You Need to Know About Pixar’s Latest

https://www.youtube.com/watch?v=_6GRAtKGrg4 Recently, I had the chance to travel to San Francisco, where I was able to visit Pixar Animation...